Equity deficit puts SmartKem (NASDAQ: SMTK) at risk of Nasdaq noncompliance
Rhea-AI Filing Summary
SmartKem, Inc. reports that Nasdaq has notified the company it is not meeting the Nasdaq Capital Market’s minimum stockholders’ equity requirement. The notice cites a stockholders’ deficit of ($127,000) in SmartKem’s Form 10-Q for the period ended June 30, 2025, below the required minimum equity of $2.5 million, and notes that the company also does not meet alternative standards based on market value or net income.
The company’s shares remain listed on Nasdaq for now while it works to regain compliance. SmartKem has until September 29, 2025 to submit a compliance plan, and Nasdaq may grant an extension to as late as February 11, 2026. SmartKem plans to submit a plan but warns there is no assurance Nasdaq will accept it or that it will be able to regain or maintain compliance.
Positive
- None.
Negative
- Nasdaq minimum equity noncompliance: SmartKem’s reported stockholders’ deficit of ($127,000) versus Nasdaq’s $2.5 million equity requirement triggers a formal deficiency notice and creates delisting risk if not cured.
Insights
Nasdaq equity deficiency raises delisting risk if SmartKem cannot regain compliance.
SmartKem, Inc. has been formally notified that it fails Nasdaq’s minimum stockholders’ equity requirement, with a reported stockholders’ deficit of ($127,000) versus the $2.5 million threshold as of its June 30, 2025 Form 10-Q. The company also does not qualify under Nasdaq’s alternative standards based on market value of listed securities or net income.
This situation means the listing remains in place for now, but SmartKem moves into a remediation phase with clear deadlines. The company must submit a plan to Nasdaq by September 29, 2025, and, if accepted, could have until February 11, 2026 to regain compliance under Listing Rule 5550(b)(1). If the plan is rejected or compliance is not regained within any granted extension, the matter could move to a hearings panel and potentially lead to delisting.
The company states it intends to file a compliance plan but explicitly acknowledges there is no assurance Nasdaq will accept it or that compliance with this or other requirements will be maintained. For investors, the key uncertainty is whether SmartKem can improve its equity position and satisfy Nasdaq’s standards within the available timeframe; the eventual outcome will depend on steps the company takes and Nasdaq’s determinations.